Treatment & Outcomes of Diabetes Patients During the COVID-19 Pandemic

After nearly six months of coping with the COVID-19 pandemic, InCrowd wanted to understand how diabetes patients and providers are managing their diseases and maintaining their treatment paradigms amidst the various challenges that threaten patient safety and access to care.

We would like to thank our friends at Market Cube for their help in sourcing this important research.


  • Method:
    • Physicians: 8-Minute MicroSurvey via InCrowd
    • Patients: 2-Minute MicroSurvey via InCrowd and Market Cube
  • Crowds:
    • US Primary Care Physicians (PCPs) and Endocrinologists (Endos)
    • Diabetes Patients
  • Sample Size:
    • Physicians: 102 Total
      • PCPs: 51%
      • Endos: 49%
    • Patients: 102 Total
  • Fielding Period:
    • Physicians: August 4, 2020 (3 hours)
    • Patients: August 5-7, 2020 (48 hours)
  • Screening Criteria
    • Physicians currently treating at least 15 diabetes type 1 patients and 25 type 2 patients
    • Patients actively seeking treatment for diabetes type 1 or type 2

InCrowd’s other COVID-19 Tracking Reports:

Please fill out the form below to access this content

This field is for validation purposes and should be left unchanged.

Related Resources

Five Ways to Improve MedTech DTC Patient Engagement

Five Ways to Improve MedTech DTC Patient Engagement

US Patient & Physician Perspectives For this year's DTC National Conference, InCrowd wanted to demonstrate the ways in which diabetic patients perceive DTC ads for medical devices designed to help treat their condition. We also examined how treating...

read more
Pre-ASCO Excitement Report

Pre-ASCO Excitement Report

Instant Insights It’s just 3 weeks until ASCO (American Society of Clinical Oncology’s annual meeting), and oncologists have shared with us the agenda topics that most interest them. Immunotherapies topped the list, with CAR-T the most popular among them. Take a look...

read more